My major interest is in the utility of human induced pluripotent stem cell (iPSC) technology for disease modelling and drug discovery of neurological disorders. I am currently working for IMI-stemBANCC consortium and involved in generating and establishing patient-specific iPSC lines and their differentiation into disease-affected cell types to model Alzheimer’s disease and migraine. I have expertise in establishing in vitro models of neurovascular cell types from patient iPSCs. Many neurodegenerative and neurodevelopmental conditions critically involve crosstalk between neural and vascular components. Neurovascular models would help in establishing robust disease-relevant phenotype and enable setting up physiologically relevant in vitro assays at the earliest stages of drug discovery.